Ohnishi Kenji, Kato Yasuyuki
Department of Infectious Diseases, Tokyo Metropolitan Bokutoh General Hospital, 4-23-15 Kohtohbashi, Sumida City, Tokyo 130-8575.
Intern Med. 2003 Jan;42(1):41-3. doi: 10.2169/internalmedicine.42.41.
To investigate whether praziquantel is effective against diphyllobothriasis nihonkaiense at doses less than the conventional dose.
Fourteen Japanese men with diphyllobopthriasis nihonkaiense were treated with a single administration of praziquantel at 5-10 mg/kg.
Twelve patients expelled a complete integrated Diphyllobothrium nihonkaiense with its scolex. One patient expelled an integrated D. nihonkaiense without its scolex, and one patient expelled 2 complete integrated D. nihonkaiense with their scolex, and an integrated D. nihonkaiense without its scolex. The lack of eggs in stool samples was confirmed in these 2 patients after the end of therapy. All patients had not expelled proglottides after the end of therapy for more than 1 year. No side effects were identified in any of the patients.
All patients were considered to be cured. Our results indicate that the oral administration of a single dose of praziquantel at 5-10 mg/kg is effective and safe against D. nihonkaiense infections.
研究吡喹酮在低于常规剂量时对日本裂头绦虫病是否有效。
14名患日本裂头绦虫病的日本男性接受了单次口服5 - 10mg/kg吡喹酮的治疗。
12名患者排出了完整的、带有头节的日本裂头绦虫。1名患者排出了不带头节的完整日本裂头绦虫,1名患者排出了2条完整的、带有头节的日本裂头绦虫以及1条不带头节的完整日本裂头绦虫。治疗结束后,这2名患者的粪便样本中未检测到虫卵。所有患者在治疗结束1年多后均未排出节片。未发现任何患者有副作用。
所有患者均被认为已治愈。我们的结果表明,单次口服5 - 10mg/kg吡喹酮对日本裂头绦虫感染有效且安全。